Top Markets
#1 Tornado Cash Tornado Cash +6.24%
#2 Story Story +4.55%
#3 UnifAI Network UnifAI Network +4.47%
#4 TENDIES TENDIES +3.72%
#5 Dual Dual +2.92%
#6 Seeker Seeker +2.82%
#7 Cash Cat Cash Cat +2.58%
#8 Figure Heloc Figure Heloc +2.55%
#9 HOME HOME +2.38%
#10 Orochi Network Orochi Network +2.35%
Coin of the day
Tornado Cash Tornado Cash
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Rang in aandelen #16450
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Aandeelprijs
$4.64
Laatst gesynchroniseerd: 2022-09-12
Marktkapitalisatie
$293.43M
Verandering (1 dag)
0.87%
Verandering (1 jaar)
0.00%
Land
US
Handel Adagio Therapeutics, Inc. (ADGI)

Categorie

Healthcare
Aandelsplitsingen voor Adagio Therapeutics, Inc. (ADGI)
Het aandeel Adagio Therapeutics, Inc. (symbool: ADGI) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Sep 02, 2026.
Eén aandeel ADGI dat vóór Sep 02, 2026 werd gekocht, staat nu gelijk aan 0 aandelen ADGI.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH